UBS analyst Andrew Stott maintained a Buy rating on LANXESS (DE:LXSG) on Thursday, setting a price target of EUR70, which is approximately 7.96% above the present share price of $77.5.
Stott expects LANXESS to post earnings per share (EPS) of $0.00 for the first quarter of 2021.
The current consensus among 17 TipRanks analysts is for a Moderate Buy rating of shares in LANXESS, with an average price target of $81.21.
The analysts price targets range from a high of $101.6 to a low of $58.57.
In its latest earnings report, released on 09/30/2020, the company reported a quarterly revenue of $1.46 billion and a net profit of $53 million. The company's market cap is $6.69 billion.
According to TipRanks.com, UBS analyst Andrew Stott is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 10.3% and a 64.24% success rate.
LANXESS AG is a holding company, which engages in the provision of specialty chemicals. It operates through the following segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, High Performance Materials, and Arlanxeo. The Advanced Intermediates segment consists of industrial chemical intermediates and a key player in the custom synthesis, and manufacturing of chemical precursors and specialty active ingredients. The Specialty Additives segment focuses on specialty additive chemicals. The Performance Chemicals segment covers application-oriented process, and functional chemicals operations. The High Performance Materials segment represents plastic activities in the engineering materials. The Arlanxeo segment refers to synthetic rubber activities. The company was founded on July 1, 2004 and is headquartered in Leverkusen, Germany.